Brennan Aoife
Insider CIK 1714563 · RARX Director · SYBX See Remarks, Director · ELYM President and CEO, Director · XLO Director · FGEN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLYM Climb Bio, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 30,902 | $13.17 | $407.0K | 87,731 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-06-27 | 2026-06-30 | 68,750 | — | $0 | 137,500 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-06-27 | 2026-06-30 | 68,750 | — | $0 | 118,633 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-01-06 | 2026-01-08 | 700,000 | — | $0 | 700,000 | SEC↗ |
| CLYM Climb Bio, Inc. | S Sale | 2025-06-30 | 2025-07-01 | 20,618 | $1.22 | $25.2K | 48,132 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2025-06-27 | 2025-07-01 | 68,750 | — | $0 | 206,250 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2025-06-27 | 2025-07-01 | 68,750 | — | $0 | 68,750 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 31,000 | — | $0 | 31,000 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-01-13 | 2025-01-15 | 1,150,000 | — | $0 | 1,150,000 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2024-06-27 | 2024-06-27 | 275,000 | — | $0 | 275,000 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2024-06-27 | 2024-06-27 | 550,000 | — | $0 | 550,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2024-06-05 | 2024-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 3,600 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 3,733 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 5,591 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 8,666 | — | $0 | 8,666 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 42,999 | — | $0 | 42,999 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 28,943 | — | $0 | 28,943 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 18,999 | — | $0 | 18,999 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 12,352 | — | $0 | 12,352 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 12,332 | — | $0 | 12,332 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 9,999 | — | $0 | 9,999 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 3,600 | — | $0 | 3,600 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 3,733 | — | $0 | 3,733 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-11-10 | 2023-11-14 | 5,591 | — | $0 | 5,591 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 42,999 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 9,999 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 12,332 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 12,352 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 18,999 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 28,943 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | D To issuer deriv | 2023-11-10 | 2023-11-14 | 8,666 | — | $0 | 0 | SEC↗ |
| FGEN FIBROGEN INC | S Sale | 2023-06-09 | 2023-06-09 | 1,994 | $16.74 | $33.4K | 30,686 | SEC↗ |
| FGEN FIBROGEN INC | S Sale | 2023-06-09 | 2023-06-09 | 2,739 | $17.52 | $48.0K | 27,947 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 32,680 | SEC↗ |
| SYBX SYNLOGIC, INC. | S Sale | 2023-04-03 | 2023-04-05 | 19,042 | $0.58 | $11.0K | 256,301 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 24,391 | SEC↗ |
| SYBX SYNLOGIC, INC. | S Sale | 2022-04-04 | 2022-04-06 | 8,894 | $2.45 | $21.8K | 275,343 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2022-02-04 | 2022-02-08 | 434,160 | — | $0 | 434,160 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2022-02-04 | 2022-02-08 | 106,920 | — | $0 | 284,237 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 8,614 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2021-03-10 | 2021-03-12 | 285,000 | — | $0 | 285,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2021-03-10 | 2021-03-12 | 71,250 | — | $0 | 177,317 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2020-08-05 | 2020-08-07 | 6,496 | — | $0 | 6,496 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2020-08-05 | 2020-08-07 | 10,400 | — | $0 | 10,400 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2020-08-05 | 2020-08-07 | 3,914 | — | $0 | 3,914 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 25,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2020-03-10 | 2020-03-12 | 185,300 | — | $0 | 185,300 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2020-03-10 | 2020-03-12 | 46,300 | — | $0 | 106,067 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2019-09-23 | 2019-09-25 | 8,000 | — | $0 | 59,767 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2019-03-05 | 2019-03-06 | 185,000 | — | $0 | 185,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2018-10-31 | 2018-11-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-09-21 | 2018-09-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2018-06-05 | 2018-06-06 | 54,000 | — | $0 | 54,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2018-03-14 | 2018-03-15 | 56,000 | — | $0 | 56,000 | SEC↗ |